
LeMaitre Vascular LMAT
$ 109.83
0.61%
Annual report 2025
added 02-26-2026
LeMaitre Vascular P/CF Ratio 2011-2026 | LMAT
Annual P/CF Ratio LeMaitre Vascular
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 31.2 | 46.9 | 42.2 | 43.6 | 30.2 | 23.3 | 67.9 | 28.1 | 40.8 | 29.8 | 28.4 | 30.6 | 48.9 | 27.2 | 82.8 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 82.8 | 23.3 | 40.1 |
P/CF Ratio of other stocks in the Medical instruments industry
| Issuer | P/CF Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Baxter International
BAX
|
11.4 | $ 16.47 | -1.08 % | $ 8.45 B | ||
|
Atrion Corporation
ATRI
|
32 K | - | - | $ 810 M | ||
|
Luminex Corporation
LMNX
|
39.6 | - | - | $ 1.75 B | ||
|
Akers Biosciences, Inc.
AKER
|
-0.0678 | - | -9.52 % | $ 20.6 M | ||
|
Alcon
ALC
|
31.6 | $ 74.46 | -0.25 % | $ 40.4 B | ||
|
The Cooper Companies
COO
|
20.5 | $ 69.5 | -1.13 % | $ 13.8 B | ||
|
Antares Pharma, Inc.
ATRS
|
108 | - | - | $ 955 M | ||
|
Cantel Medical Corp.
CMD
|
22.1 | - | -1.18 % | $ 3.4 B | ||
|
CRH Medical Corporation
CRHM
|
4.24 | - | - | $ 282 M | ||
|
Hill-Rom Holdings, Inc.
HRC
|
16.1 | - | -0.05 % | $ 10.3 B | ||
|
Varian Medical Systems, Inc.
VAR
|
22.2 | - | -0.02 % | $ 16.3 B | ||
|
electroCore
ECOR
|
-0.0068 | $ 7.04 | - | $ 59.7 K | ||
|
Ekso Bionics Holdings
EKSO
|
-2.21 | $ 9.6 | -1.54 % | $ 23.3 M | ||
|
BioLife Solutions
BLFS
|
135 | $ 19.0 | -1.4 % | $ 875 M | ||
|
AtriCure
ATRC
|
27.2 | $ 28.76 | -1.47 % | $ 1.37 B | ||
|
Glaukos Corporation
GKOS
|
-74.5 | $ 115.08 | -1.41 % | $ 5.57 B | ||
|
Haemonetics Corporation
HAE
|
16.9 | $ 58.1 | -0.54 % | $ 2.92 B | ||
|
Harvard Bioscience
HBIO
|
3.1 | $ 5.53 | - | $ 245 M | ||
|
iRhythm Technologies
IRTC
|
62.8 | $ 115.36 | -1.59 % | $ 3.69 B | ||
|
Repro Med Systems
KRMD
|
431 | $ 4.25 | -0.23 % | $ 196 M | ||
|
Masimo Corporation
MASI
|
45.6 | $ 178.34 | -0.08 % | $ 9.51 B | ||
|
Microbot Medical
MBOT
|
-9.2 | $ 2.32 | -1.91 % | $ 106 M | ||
|
Milestone Scientific
MLSS
|
-8.16 | $ 0.29 | - | $ 23.8 M | ||
|
Envista Holdings Corporation
NVST
|
17.5 | $ 25.51 | -1.22 % | $ 4.29 B | ||
|
Pro-Dex
PDEX
|
-89.4 | $ 48.53 | - | $ 160 M | ||
|
ICU Medical
ICUI
|
20.4 | $ 121.67 | -1.08 % | $ 3 B | ||
|
ResMed
RMD
|
99.8 | $ 224.04 | -0.34 % | $ 32.7 B | ||
|
InfuSystem Holdings
INFU
|
8.33 | $ 9.43 | - | $ 195 M | ||
|
Retractable Technologies
RVP
|
-2.84 | $ 0.71 | -0.07 % | $ 21.3 M | ||
|
Isoray
ISR
|
-1.34 | - | 0.03 % | $ 108 M | ||
|
Intuitive Surgical
ISRG
|
56.4 | $ 449.17 | -0.75 % | $ 160 B | ||
|
STAAR Surgical Company
STAA
|
-27.5 | $ 21.44 | 2.29 % | $ 1.06 B | ||
|
Stereotaxis
STXS
|
-12.5 | $ 1.85 | -1.86 % | $ 168 M | ||
|
Teleflex Incorporated
TFX
|
52.2 | $ 114.86 | -0.2 % | $ 5.13 B | ||
|
Merit Medical Systems
MMSI
|
16.3 | $ 66.72 | -1.61 % | $ 3.95 B | ||
|
Utah Medical Products
UTMD
|
13.6 | $ 63.75 | 1.3 % | $ 207 M | ||
|
Predictive Oncology
POAI
|
-0.0983 | - | - | $ 31.1 M | ||
|
Pulse Biosciences
PLSE
|
-31.5 | $ 21.68 | -5.49 % | $ 1.46 B | ||
|
West Pharmaceutical Services
WST
|
23.3 | $ 258.0 | 0.4 % | $ 18.7 B | ||
|
DENTSPLY SIRONA
XRAY
|
10.7 | $ 11.45 | -1.63 % | $ 2.28 B | ||
|
NeuroMetrix
NURO
|
-1.22 | - | 5.05 % | $ 9.02 M | ||
|
STERIS plc
STE
|
21 | $ 219.18 | -0.37 % | $ 21.6 B | ||
|
AngioDynamics
ANGO
|
-35.1 | $ 9.51 | -3.35 % | $ 389 M | ||
|
Becton, Dickinson and Company
BDX
|
29.1 | $ 154.32 | -0.59 % | $ 44.4 B | ||
|
Nephros
NEPH
|
27.3 | $ 2.81 | -1.75 % | $ 29.2 M | ||
|
OraSure Technologies
OSUR
|
-4.8 | $ 3.05 | -1.14 % | $ 224 M | ||
|
Repligen Corporation
RGEN
|
0.0946 | $ 116.46 | -0.42 % | $ 6.49 M |